Contentious issues with supply and demand
8 Apr 2015
A sustainable blood supply depends on an intricate balance of unpaid donors' gifts with patients' needs. This session explores some of the contentious issues associated with blood supply and demand in Australia.
- Improve understanding of current supply and demand issues.
- Identify issues affecting O negative red cell demand.
- Evaluate the evidence for which patients require CMV negative blood products.
- Explore the use of Group A plasma instead of Group AB plasma.
Chair: Mr Stuart Chesneau, Blood Service.
Presentation 1: Questioning the evidence and demand for CMV negative blood: patient need vs clinical request.
Presenter: Ms Lee Nicholls, Transfusion Medicine Scientist, Blood Service
|Presentation 2: Use of group A plasma instead of group AB plasma.
Presenter: Ms Liz Lennox, Transfusion Medicine Scientist, Blood Service
|Presentation 3: Appropriate use of phenotyped / Kell negative red cells in a decreasing red cell issue environment.
Presenters: Ms Natalie Stewart and Ms Anne Johnston, Transfusion Medicine Scientists, Blood Service
|Presentation 4: Increased sustained use of O negative red cells in a decreasing red cell issue environment.
Presenter: Mr Stuart Chesneau, National Supply Chain Manager, Blood Service.